Omnicell (OMCL) Tops Q3 EPS by 17c

Omnicell (NASDAQ: OMCL) reported Q3 EPS of $1.08, $0.17 better than the analyst estimate of $0.91. Revenue for the quarter came in at $296 million versus the consensus estimate of $284.74 million.

GUIDANCE:

Omnicell sees FY2021 EPS of $3.80-$3.85, versus the consensus of $3.73. Omnicell sees FY2021 revenue of $1.129-1.134 billion, versus the consensus of $1.11 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI